Serum Interleukin (IL)-15 as a biomarker of Alzheimer's disease

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Bishnoi, Ram J ^a   Palmer, Raymond F ^b   Royall, Donald R ^c  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEFAULT MODE NETWORK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PROTEIN BLOOD LEVEL; BLOOD; COHORT ANALYSIS; PATHOLOGY; THEORETICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOMARKERS; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-15; MALE; MODELS, THEORETICAL;

EID: 84923349472     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117282     Document Type: Article

References (79)

1. Benveniste EN, Nguyen VT, O'Keefe GM (2001) Immunological aspects of microglia: Relevance to alzheimer's disease. Neurochem Int 39: 381-391. PMID: 11578773
2. Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, et al. (2010) A meta-analysis of cytokines in alzheimer's disease. Biol Psychiatry 68: 930-941. doi: 10.1016/j.biopsych.2010.06.012 PMID: 20692646
3. Rogers J, Webster S, Lue LF, Brachova L, Civin WH, et al. (1996) Inflammation and alzheimer's disease pathogenesis. Neurobiol Aging 17: 681-686. PMID: 8892340
4. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, et al. (2000) Inflammation and alzheimer's disease. Neurobiol Aging 21: 383-421. PMID: 10858586
5. Cunningham C, Campion S, Lunnon K, Murray CL, Woods JF, et al. (2009) Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry 65: 304-312. doi: 10.1016/j.biopsych.2008.07.024 PMID: 18801476
6. Holmes C, Cunningham C, Zotova E, Culliford D, Perry VH (2011) Proinflammatory cytokines, sickness behavior, and alzheimer disease. Neurology 77: 212-218. doi: 10.1212/WNL.0b013e318225ae07 PMID: 21753171
7. Emmerling MR, Watson MD, Raby CA, Spiegel K (2000) The role of complement in alzheimer's disease pathology. Biochim Biophys Acta 1502: 158-171. PMID: 10899441
8. Trivedi A, Olivas AD, Noble-Haeusslein LJ (2006) Inflammation and spinal cord injury: Infiltrating leukocytes as determinants of injury and repair processes. Clin Neurosci Res 6: 283-292. PMID: 18059979
9. Lewitus GM, Cohen H, Schwartz M (2008) Reducing post-traumatic anxiety by immunization. Brain Behav Immun 22: 1108-1114. doi: 10.1016/j.bbi.2008.05.002 PMID: 18562161
10. Shechter R, London A, Varol C, Raposo C, Cusimano M, et al. (2009) Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 6: e1000113. doi: 10.1371/journal.pmed.1000113 PMID: 19636355
11. Baruch K, Schwartz M (2013) CNS-specific T cells shape brain function via the choroid plexus. Brain Behav Immun 34: 11-16. doi: 10.1016/j.bbi.2013.04.002 PMID: 23597431
12. Pan W, Yu C, Hsuchou H, Zhang Y, Kastin AJ (2008) Neuroinflammation facilitates LIF entry into brain: Role of TNF. Am J Physiol Cell Physiol 294: C1436-42. doi: 10.1152/ajpcell.00489.2007 PMID: 18385284
13. Threlkeld SW, Lynch JL, Lynch KM, Sadowska GB, Banks WA, et al. (2010) Ovine proinflammatory cytokines cross the murine blood-brain barrier by a common saturable transport mechanism. Neuroimmunomodulation 17: 405-410. doi: 10.1159/000288265 PMID: 20516722
14. Lee YB, Satoh J, Walker DG, Kim SU (1996) Interleukin-15 gene expression in human astrocytes and microglia in culture. Neuroreport 7: 1062-1066. PMID: 8804052
15. Jonuleit H, Wiedemann K, Muller G, Degwert J, Hoppe U, et al. (1997) Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: A role for IL-15 in attraction of T cells. J Immunol 158: 2610-2615. PMID: 9058793
16. Hall JR, Wiechmann AR, Johnson LA, Edwards M, Barber RC, et al. (2013) Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in alzheimer's disease. J Alzheimers Dis 35: 363-371. doi: 10.3233/JAD-122359 PMID: 23403534
17. Hall JR, Johnson LA, Barber RC, Vo HT, Winter AS, et al. (2012) Biomarkers of basic activities of daily living in alzheimer's disease. J Alzheimers Dis 31: 429-437. doi: 10.3233/JAD-2012-111481 PMID: 22571981
18. Carson VB, Yambor SL (2012) Managing patients with bipolar disorder at home: A family affair and a psychiatric challenge in home healthcare. Home Healthc Nurse 30: 280-91; quiz 291-3. doi: 10.1097/NHH.0b013e318252c52b PMID: 22565349
19. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, et al. (1994) Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264: 965-968. PMID: 8178155
20. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, et al. (1994) Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180: 1395-1403. PMID: 7523571
21. Hanisch UK, Lyons SA, Prinz M, Nolte C, Weber JR, et al. (1997) Mouse brain microglia express inter-leukin-15 and its multimeric receptor complex functionally coupled to janus kinase activity. J Biol Chem 272: 28853-28860. PMID: 9360952
22. Kurowska M, Rudnicka W, Maslinska D, Maslinski W (2002) Expression of IL-15 and IL-15 receptor isoforms in select structures of human fetal brain. Ann N Y Acad Sci 966: 441-445. PMID: 12114302
23. Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, et al. (2005) Targeting interleukin-15 in patients with rheumatoid arthritis: A proof-of-concept study. Arthritis & Rheumatism 52: 2686-2692. PMID: 16142748
24. Ruchatz H, Leung BP, Wei XQ, McInnes IB, Liew FY (1998) Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: A role for IL-15 in development of antigen-induced immunopathology. J Immunol 160: 5654-5660. PMID: 9605172
25. Rentzos M, Zoga M, Paraskevas GP, Kapaki E, Rombos A, et al. (2006) IL-15 is elevated in cerebrospinal fluid of patients with alzheimer's disease and frontotemporal dementia. J Geriatr Psychiatry Neurol 19: 114-117. PMID: 16690997
26. Rentzos M, Paraskevas GP, Kapaki E, Nikolaou C, Zoga M, et al. (2007) Circulating interleukin-15 in dementia disorders. J Neuropsychiatry Clin Neurosci 19: 318-325. PMID: 17827418
27. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566-572. PMID: 7104545
28. Royall DR, Palmer RF, O'Bryant SE, Texas Alzheimer's Research and Care Consortium (2012) Validation of a latent variable representing the dementing process. J Alzheimers Dis 30: 639-649. doi: 10.3233/JAD-2012-120055 PMID: 22451315
29. Royall DR, Palmer RF, Vidoni ED, Honea RA, Burns JM (2012) The default mode network and related right hemisphere structures may be the key substrates of dementia. J Alzheimers Dis 32: 467-478. doi: 10.3233/JAD-2012-120424 PMID: 22842866
30. Bishnoi RJ, Palmer RF, Royall DR (2014) Vitamin D binding protein as a serum biomarker of alzheimer's disease. J Alzheimers Dis.
31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on alzheimer's disease. Neurology 34: 939-944. PMID: 6610841
32. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198. PMID: 1202204
33. Waring S, O'Bryant SE, Reisch JS, Diaz-Arrastia R, Knebl J, et al. (2008) The texas alzheimer's research consortium longitudinal research cohort: Study design and baseline characteristics. Texas Pub Health Journal: 9-13.
34. Arbuckle JL (2006) Analysis of moment structures-AMOS.
35. Royall DR, Palmer RF (2012) Getting past "g": Testing a new model of dementing processes in persons without dementia. J Neuropsychiatry Clin Neurosci 24: 37-46. doi: 10.1176/appi.neuropsych.11040078 PMID: 22450612
36. Gavett BE, Vudy V, Jeffrey M, John SE, Gurnani AS, et al. (2014) The delta latent dementia phenotype in the uniform data set: Cross-validation and extension. Neuropsychology.
37. Royall DR, Palmer RF, Texas Alzheimer's Research and Care Consortium (2014) Does ethnicity moderate dementia's biomarkers? Neurobiol Aging 35: 336-344. doi: 10.1016/j.neurobiolaging.2013.08.006 PMID: 24054829
38. Palmer RF, Royall DR (2010) Missing data? plan on it! J Am Geriatr Soc 58 Suppl 2: S343-8. doi: 10.1111/j.1532-5415.2010.03053.x PMID: 21029065
39. Muthén B, Tam T, Muthén L, Stolzenberg R, Hollis M (1993) Latent variable modeling in the LISCOMP framework: Measurement of attitudes towards career choice. In: Krebs D, Schmidt P, editors. New Directions in Attitude Measurement. Berlin, Germany: Walter de Gruyter. pp. 277-290.
40. Muthén BO (1989) Dichotomous factor analysis of symptom data〈br /〉. Sociol. Meth. Res. 18: 19-65.
41. Muthén BO (1979) A structural model with latent variables. Journal of the American Statistical Association 74: 807-811.
42. Bollen KA, Long JS (1993) Testing structural equation models. Thousand Oaks, CA: Sage Publications. PMID: 25590127
43. Wheaton B, Muthén B, Alwin D, Summers G (1977) Assessing reliability and stability in panel models. In: Heise DR, editor. Sociological Methodology. San Francisco: Jossey-Bass, Inc. pp. 84-136.
44. Bentler PM (1990) Comparative fit indexes in structural models. Psychol Bull 107: 238-246. PMID: 2320703
45. Browne M, Cudeck R (1993) Alternative ways of assessing model fit. In: Bollen KA, Long JS, editors. Testing structural equation models. Thousand Oaks, CA: Sage Publications. pp. 136-162.
46. Judd CM, Kenny DA (1981) Process analysis: Estimating mediation in treatment evaluations. Evaluation Review: 602-619.
47. Bentler PM, Bonnet DC (1980) Significance tests and goodness of fit in the analysis of covariance structures. Psychological bulletin 88: 588-606.
48. Cohen J (1983) The cost of dichotomization. Applied Psychological Measurement 7: 249-253.
49. Kreiner S (1989) Statistical analysis of complex health and social data. Soc Sci Med 29: 253-258. PMID: 2665111
50. Royall DR, Palmer R, Mulroy AR, Polk MJ, Roman GC, et al. (2002) Pathological determinants of the transition to clinical dementia in alzheimer's disease. Exp Aging Res 28: 143-162. PMID: 11928525
51. Marques F, Sousa JC, Sousa N, Palha JA (2013) Blood-brain-barriers in aging and in alzheimer's disease. Mol Neurodegener 8: 38-1326-8-38. doi: 10.1186/1750-1326-8-38. Blood-brain-barriers PMID: 24148264
52. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, et al. (2005) Molecular, structural, and functional characterization of alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25: 7709-7717. PMID: 16120771
53. Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in alzheimer's disease: From synapses toward neural networks. Nat Neurosci 13: 812-818. doi: 10.1038/nn.2583 PMID: 20581818
54. van den Heuvel MP, Hulshoff Pol HE (2010) Exploring the brain network: A review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol 20: 519-534. doi: 10.1016/j.euroneuro.2010.03.008 PMID: 20471808
55. Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD (2009) Neurodegenerative diseases target large-scale human brain networks. Neuron 62: 42-52. doi: 10.1016/j.neuron.2009.03.024 PMID: 19376066
56. Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, et al. (2010) Functional alterations in memory networks in early alzheimer's disease. Neuromolecular Med 12: 27-43. doi: 10.1007/s12017-009-8109-7 PMID: 20069392
57. Agosta F, Pievani M, Geroldi C, Copetti M, Frisoni GB, et al. (2012) Resting state fMRI in alzheimer's disease: Beyond the default mode network. Neurobiol Aging 33: 1564-1578. doi: 10.1016/j.neurobiolaging.2011.06.007 PMID: 21813210
58. Liang P, Wang Z, Yang Y, Li K (2012) Three subsystems of the inferior parietal cortex are differently affected in mild cognitive impairment. J Alzheimers Dis 30: 475-487. doi: 10.3233/JAD-2012-111721 PMID: 22451310
59. Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, et al. (2007) Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci 27: 2349-2356. PMID: 17329432
60. Gomez-Nicola D, Valle-Argos B, Pita-Thomas DW, Nieto-Sampedro M (2008) Interleukin 15 expression in the CNS: Blockade of its activity prevents glial activation after an inflammatory injury. Glia 56: 494-505. doi: 10.1002/glia.20628 PMID: 18240307
61. Gomez-Nicola D, Valle-Argos B, Suardiaz M, Taylor JS, Nieto-Sampedro M (2008) Role of IL-15 in spinal cord and sciatic nerve after chronic constriction injury: Regulation of macrophage and T-cell infiltration. J Neurochem 107: 1741-1752. doi: 10.1111/j.1471-4159.2008.05746.x PMID: 19014377
62. Gomez-Nicola D, Valle-Argos B, Nieto-Sampedro M (2010) Blockade of IL-15 activity inhibits microglial activation through the NFkappaB, p38, and ERK1/2 pathways, reducing cytokine and chemokine release. Glia 58: 264-276. doi: 10.1002/glia.20920 PMID: 19610094
63. Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Prog Neurobiol 76: 77-98. PMID: 16081203
64. Takano M, Nishimura H, Kimura Y, Mokuno Y, Washizu J, et al. (1998) Protective roles of T cells and in-terleukin-15 in escherichia coli infection in mice. Infect Immun 66: 3270-3278. PMID: 9632595
65. Huang Z, Ha GK, Petitto JM (2007) IL-15 and IL-15R alpha gene deletion: Effects on T lymphocyte trafficking and the microglial and neuronal responses to facial nerve axotomy. Neurosci Lett 417: 160-164. PMID: 17418948
66. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, et al. (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia. J Neurosci 20: 6309-6316. PMID: 10934283
67. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, et al. (2009) Cortical hubs revealed by intrinsic functional connectivity: Mapping, assessment of stability, and relation to alzheimer's disease. Journal of Neuroscience 29: 1860-1873. doi: 10.1523/JNEUROSCI.5062-08.2009 PMID: 19211893
68. Tomas-Camardiel M, Rite I, Herrera AJ, de Pablos RM, Cano J, et al. (2004) Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis 16: 190-201. PMID: 15207276
69. Simard AR, Rivest S (2004) Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J 18: 998-1000. PMID: 15084516
70. Djukic M, Mildner A, Schmidt H, Czesnik D, Bruck W, et al. (2006) Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain 129: 2394-2403. PMID: 16891321
71. Pan W, Wu X, He Y, Hsuchou H, Huang EY, et al. (2013) Brain interleukin-15 in neuroinflammation and behavior. Neurosci Biobehav Rev 37: 184-192. doi: 10.1016/j.neubiorev.2012.11.009 PMID: 23201098
72. Song L, Ge S, Pachter JS (2007) Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood 109: 1515-1523. PMID: 17023578
73. Pan W, Stone KP, Hsuchou H, Manda VK, Zhang Y, et al. (2011) Cytokine signaling modulates blood-brain barrier function. Curr Pharm Des 17: 3729-3740. PMID: 21834767
74. Stone KP, Kastin AJ, Pan W (2011) NFkB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia. Cell Physiol Biochem 28: 115-124. doi: 10.1159/000331720 PMID: 21865854
75. Pan W, Yu C, Hsuchou H, Khan RS, Kastin AJ (2009) Cerebral microvascular IL15 is a novel mediator of TNF action. J Neurochem 111: 819-827. doi: 10.1111/j.1471-4159.2009.06371.x PMID: 19719822
76. Gomez-Nicola D, Valle-Argos B, Pallas-Bazarra N, Nieto-Sampedro M (2011) Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells. Mol Biol Cell 22: 1960-1970. doi: 10.1091/mbc.E11-01-0053 PMID: 21508317
77. Huang Y-, Cheng S-, Chueh S-, Tsai Y-, Liou N-, et al. (2009) Effects of interleukin-15 on neuronal differentiation of neural stem cells. Brain Res 1304: 38-48. doi: 10.1016/j.brainres.2009.09.009 PMID: 19747902
78. Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, et al. (2006) Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Molecular and Cellular Neuroscience 31: 149-160. PMID: 16297637
79. Waldau B, Shetty AK (2008) Behavior of neural stem cells in the alzheimer brain. Cell Mol Life Sci 65: 2372-2384. doi: 10.1007/s00018-008-8053-y PMID: 18500448